These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27334485)

  • 1. Diabetes mellitus is associated with adverse structural and functional cardiac remodelling in chronic heart failure with reduced ejection fraction.
    Walker AM; Patel PA; Rajwani A; Groves D; Denby C; Kearney L; Sapsford RJ; Witte KK; Kearney MT; Cubbon RM
    Diab Vasc Dis Res; 2016 Sep; 13(5):331-40. PubMed ID: 27334485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy.
    Tanaka H; Tatsumi K; Matsuzoe H; Matsumoto K; Hirata KI
    Cardiovasc Diabetol; 2020 Jun; 19(1):84. PubMed ID: 32534593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function.
    Johansson I; Dahlström U; Edner M; Näsman P; Rydén L; Norhammar A
    Diab Vasc Dis Res; 2018 Nov; 15(6):494-503. PubMed ID: 30176743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline.
    Julián MT; Alonso N; Lupón J; Gavidia-Bovadilla G; Ferrer E; de Antonio M; López-Ayerbe J; Domingo M; Santiago-Vacas E; Zamora E; Codina P; Moliner P; Núñez J; Santesmases J; Puig-Domingo M; Bayes-Genis A
    Cardiovasc Diabetol; 2020 Mar; 19(1):38. PubMed ID: 32293458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus.
    Liu JH; Chen Y; Yuen M; Zhen Z; Chan CW; Lam KS; Tse HF; Yiu KH
    Cardiovasc Diabetol; 2016 Feb; 15():22. PubMed ID: 26842466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the role of left atrial strain using two-dimensional speckle tracking echocardiography in patients with diabetes mellitus and heart failure with preserved left ventricular ejection fraction.
    Georgievska-Ismail L; Zafirovska P; Hristovski Z
    Diab Vasc Dis Res; 2016 Nov; 13(6):384-394. PubMed ID: 27407084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
    Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus.
    Yokota S; Tanaka H; Mochizuki Y; Soga F; Yamashita K; Tanaka Y; Shono A; Suzuki M; Sumimoto K; Mukai J; Suto M; Takada H; Matsumoto K; Hirota Y; Ogawa W; Hirata KI
    Cardiovasc Diabetol; 2019 Dec; 18(1):166. PubMed ID: 31805945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis.
    Bouthoorn S; Valstar GB; Gohar A; den Ruijter HM; Reitsma HB; Hoes AW; Rutten FH
    Diab Vasc Dis Res; 2018 Nov; 15(6):477-493. PubMed ID: 30037278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement?
    Mohamedali B; Yost G; Bhat G
    Tex Heart Inst J; 2017 Apr; 44(2):115-119. PubMed ID: 28461796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between heart rate variability and left ventricular layer-specific deformation in uncomplicated diabetic patients.
    Vukomanovic V; Tadic M; Suzic-Lazic J; Kocijancic V; Celic V
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):481-490. PubMed ID: 27853970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Changes in Cardiac Structure and Function From Adolescence to Young Adulthood in Participants With Type 2 Diabetes Mellitus: The TODAY Follow-Up Study.
    TODAY Study Group
    Circ Heart Fail; 2020 Jun; 13(6):e006685. PubMed ID: 32498621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes and heart failure: a practically oriented critical appraisal].
    Halle M; Gitt AK; Hanefeld M; Kellerer M; Marx N; Meier JJ; Schumm-Draeger PM; Bramlage P; Tschoepe D
    Dtsch Med Wochenschr; 2012 Mar; 137(9):437-41. PubMed ID: 22354800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure.
    Wang Y; Yang H; Huynh Q; Nolan M; Negishi K; Marwick TH
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1390-1400. PubMed ID: 29778859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure.
    Swoboda PP; McDiarmid AK; Erhayiem B; Ripley DP; Dobson LE; Garg P; Musa TA; Witte KK; Kearney MT; Barth JH; Ajjan R; Greenwood JP; Plein S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28716801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
    Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective development and validation of a model to predict heart failure hospitalisation.
    Cubbon RM; Woolston A; Adams B; Gale CP; Gilthorpe MS; Baxter PD; Kearney LC; Mercer B; Rajwani A; Batin PD; Kahn M; Sapsford RJ; Witte KK; Kearney MT
    Heart; 2014 Jun; 100(12):923-9. PubMed ID: 24647052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.